Hamburg, Germany

Klaus Seedorf

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Klaus Seedorf: Innovator in TGR5 Modulators

Introduction

Klaus Seedorf is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of TGR5 modulators. With a total of 3 patents to his name, Seedorf's work is paving the way for innovative treatments for various diseases.

Latest Patents

Seedorf's latest patents focus on TGR5 modulators and their methods of use. The applications relate to compounds of formula A, which can include salts, solvates, esters, tautomers, amino acid conjugates, or metabolites. These compounds are designed to be useful in treating a range of diseases, including metabolic, inflammatory, autoimmune, cardiac, kidney, cancer, and gastrointestinal diseases.

Career Highlights

Klaus Seedorf is currently associated with Intercept Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative approach to drug development has garnered attention in the pharmaceutical industry.

Collaborations

Seedorf has collaborated with notable colleagues, including Roberto Pellicciari and Antimo Gioiello. These partnerships have contributed to the success of his research and the advancement of TGR5 modulators.

Conclusion

Klaus Seedorf's work in the field of TGR5 modulators represents a significant advancement in the treatment of various diseases. His innovative contributions and collaborations continue to shape the future of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…